One century after its discovery vitamin D is shown to be, in fact, a pleiotropic steroid hormone which, beside regulation of calcium homeostasis and bone turnover, has anti-proliferative, pro-differentiation, anti-bacterial, immunomodulatory and anti-inflammatory properties in various cells and tissues.
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The D hormone [1α,25(OH)2D], regulated in endocrine, autocrine and paracrine manner, must be bound to the specific nuclear vitamin D receptor (VDR) to exert epigenetic and genetic effects influencing more than 2000 genes in all tissues and immune cells, essential for proliferation, differentiation and immunoregulation. VDR agonists inhibit in myeloid DCs, but not in plazmacytoid DCs, expression of surface co-stimulatory molecules such as MHC class II, CD40, CD80 and CD86. In T cells, 1,25(OH)2D decreases the production of IL-2, IL-17 and interferon-γ (IFNγ) and attenuates the cytotoxic activity and proliferation of CD4+ and CD8+ T cells, and promote the development of FoxP3+ regulatory T (TReg) cells and IL-10-producing T regulatory type 1 cells. In contrast to glucocorticoids which are non-selective immunosuppressive compaunds, 1α,25(OH) 2D induces monocyte proliferation and the expression of interleukin-1 (IL-1) and cathelicidin (an antimicrobial peptide) by macrophages, thereby contributing to innate immune responses to some bacteria. Additionally it was shown that 1α,25(OH)2D can override steroid resistance and antagonize its negative bone turnover influence.
The discovery of the immunomodulatory and antitumor properties of D-hormone prompted researchers to investigate possibility of its use as a preventive and therapeutic agent for different autoimmune and malignant diseases. New recommendations and guidelines for vitamin D supplementation, as adjunct treatment option in JIA and other chronic inflammatory rheumatic diseases, is an appealing need due to its pleiotropic effects. It can both minimize bone fragility and contribute improvement of impaired immunity regulation in rheumatic diseases in children, especially those with necessity for long term steroid treatment.
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